280 related articles for article (PubMed ID: 18682813)
1. Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.
Petrovic MG; Korosec P; Kosnik M; Osredkar J; Hawlina M; Peterlin B; Petrovic D
Mol Vis; 2008 Jul; 14():1382-7. PubMed ID: 18682813
[TBL] [Abstract][Full Text] [Related]
2. Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes.
Feghhi M; Nikzamir A; Esteghamati A; Mahmoudi T; Yekaninejad MS
Transl Res; 2011 Aug; 158(2):85-91. PubMed ID: 21757152
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).
Sajovic J; Cilenšek I; Mankoč S; Tajnšek Š; Kunej T; Petrovič D; Globočnik Petrovič M
Bosn J Basic Med Sci; 2019 Feb; 19(1):94-100. PubMed ID: 30579324
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
Shen Y; Cao H; Chen F; Suo Y; Wang N; Xu X
Acta Ophthalmol; 2020 Mar; 98(2):e212-e216. PubMed ID: 31421026
[TBL] [Abstract][Full Text] [Related]
5. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
6. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
7. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy.
Nakamura S; Iwasaki N; Funatsu H; Kitano S; Iwamoto Y
Graefes Arch Clin Exp Ophthalmol; 2009 Jan; 247(1):21-6. PubMed ID: 18709380
[TBL] [Abstract][Full Text] [Related]
8. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.
Awata T; Inoue K; Kurihara S; Ohkubo T; Watanabe M; Inukai K; Inoue I; Katayama S
Diabetes; 2002 May; 51(5):1635-9. PubMed ID: 11978667
[TBL] [Abstract][Full Text] [Related]
9. Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.
Choudhuri S; Chowdhury IH; Das S; Dutta D; Saha A; Sarkar R; Mandal LK; Mukherjee S; Bhattacharya B
Mol Cell Biochem; 2015 Jul; 405(1-2):265-79. PubMed ID: 25956512
[TBL] [Abstract][Full Text] [Related]
10. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
11. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
12. Serum and vitreous vascular endothelial growth factor levels in diabetic retinopathy.
Sozen-Delil FI; Cekic O; Haklar G
Int Ophthalmol; 2023 Jul; 43(7):2247-2255. PubMed ID: 36580154
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
14. An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy.
Szaflik JP; Wysocki T; Kowalski M; Majsterek I; Borucka AI; Blasiak J; Szaflik J
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):39-43. PubMed ID: 17849138
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.
Wu F; Phone A; Lamy R; Ma D; Laotaweerungsawat S; Chen Y; Zhao T; Ma W; Zhang F; Psaras C; Stewart JM
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):26. PubMed ID: 32084272
[TBL] [Abstract][Full Text] [Related]
16. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes.
Petrovic MG; Krkovic M; Osredkar J; Hawlina M; Petrovic D
Clin Exp Ophthalmol; 2008 Mar; 36(2):168-72. PubMed ID: 18279437
[TBL] [Abstract][Full Text] [Related]
18. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
19. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
